083251795	083251795	CD	B-NP	O
|	|	NNP	I-NP	O
RHC	RHC	NNP	I-NP	O
|	|	VBD	B-VP	O
63911803	63911803	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8439285	8439285	CD	B-NP	O
|	|	CC	I-NP	O
5/4/2004	5/4/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Hypoglycemia	Hypoglycemia	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/25/2004	4/25/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/13/2004	4/13/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
MOSZ	MOSZ	NN	B-NP	O
,	,	,	O	O
HERB	HERB	NN	B-NP	O
329-79-87-1	329-79-87-1	CD	I-NP	O
Doh	Doh	NNP	I-NP	O
Field	Field	NNP	I-NP	O
Ra	Ra	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/18/04	10/18/04	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SCHWART	SCHWART	NNP	B-NP	O
,	,	,	O	O
EDDY	EDDY	NNP	B-NP	O
QUINTON	QUINTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
defib	defib	NN	I-NP	O
/	/	SYM	B-NP	O
No	No	NN	I-NP	O
intubation	intubation	NN	I-NP	O
/	/	SYM	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/14	8/14	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
LASIX	LASIX	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	I-protein
HUMAN	HUMAN	NNP	I-NP	I-protein
4	4	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
15	15	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/14	8/14	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ISORDIL	ISORDIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
NITROGLYCERIN	NITROGLYCERIN	NNP	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	HYPH	O	O
0.4	0.4	CD	B-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
q5min	q5min	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
NEPHROCAPS	NEPHROCAPS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
NEPHRO-VIT	NEPHRO-VIT	NN	I-NP	O
RX	RX	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/8/04	4/8/04	CD	B-NP	O
by	by	IN	B-PP	O
MAISON	MAISON	NNP	B-NP	O
,	,	,	O	O
STANTON	STANTON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
takes	take	VBZ	B-VP	O
chronically	chronically	RB	B-NP	O
LIPITOR	LIPITOR	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/18/04	10/18/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
LOPRESSOR	LOPRESSOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

HYTRIN	HYTRIN	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
TERAZOSIN	TERAZOSIN	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
PEPCID	PEPCID	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FAMOTIDINE	FAMOTIDINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Augustus	Augustus	NNP	I-NP	O
Alea	Alea	NNP	I-NP	O
8/28/04	8/28/04	CD	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
AM	AM	VBP	B-VP	O
8/11/04	8/11/04	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Arden	Arden	NNP	B-NP	O
Friedman	Friedman	NNP	I-NP	O
6/15/04	6/15/04	CD	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
AM	AM	NN	I-NP	O
6/21/04	6/21/04	CD	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
ROMI	ROMI	NN	B-NP	O
,	,	,	O	O
hypoglycemia	hypoglycemia	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hypoglycemia	Hypoglycemia	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PVD	PVD	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	B-protein
vascular	vascular	JJ	I-NP	I-protein
disease	disease	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
DM	DM	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
diabetes	diabetes	NN	I-NP	I-protein
mellitus	mellitus	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
legally	legally	RB	B-ADJP	O
blind	blind	JJ	I-ADJP	O
-LRB-	-LRB-	HYPH	B-NP	O
visual	visual	JJ	I-NP	O
impairment	impairment	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
67F	67F	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
mult	mult	NN	I-NP	B-protein
CV	CV	NN	I-NP	I-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
presents	present	VBZ	B-VP	O
following	follow	VBG	B-PP	O
hypoglycemic	hypoglycemic	JJ	B-NP	O
episode	episode	NN	I-NP	O
and	and	CC	O	O
poss	poss	JJ	B-NP	O
seizure	seizure	NN	I-NP	O
.	.	.	O	O

Found	Found	RB	B-ADVP	O
this	this	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
by	by	IN	B-PP	O
family	family	NN	B-NP	O
unresponsive	unresponsive	JJ	B-ADJP	O
,	,	,	O	O
frothing	frothing	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

FS	FS	NN	B-NP	O
=	=	SYM	B-VP	O
30	30	CD	B-NP	O
by	by	IN	B-PP	O
EMS	EMS	NN	B-NP	O
and	and	CC	I-NP	O
D50	D50	NN	I-NP	O
ampule	ampule	NN	I-NP	O
given	give	VBN	B-PP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
.	.	.	O	O

Was	Wa	NNS	B-NP	B-protein
oriented	orient	VBN	B-VP	O
by	by	IN	B-PP	O
NMC	NMC	NN	B-NP	O
ED	ED	NN	I-NP	O
but	but	CC	O	O
suddenly	suddenly	RB	B-VP	O
experienced	experience	VBD	I-VP	O
7-8/10	7-8/10	CD	B-NP	O
SSCP	SSCP	NN	I-NP	O
w/SOB/N	w/SOB/N	NN	I-NP	O
/	/	SYM	B-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
.	.	.	O	O

ST	ST	JJ	B-NP	O
elevations	elevation	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
aVF	aVF	NN	B-NP	O
,	,	,	O	O
V4-V6	V4-V6	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
TWI	TWI	NN	I-NP	B-protein
I	I	NN	I-NP	I-protein
,	,	,	O	O
aVL	aVL	NN	B-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
context	context	NN	I-NP	O
.	.	.	O	O

NTG	NTG	NN	B-NP	B-protein
and	and	CC	I-NP	O
morphine	morphine	NN	I-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
1-2/10	1-2/10	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
normalized	normalize	VBD	B-VP	O
with	with	IN	B-PP	O
correction	correction	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
and	and	CC	O	O
anti-anginals	anti-anginal	NNS	B-NP	O
-LRB-	-LRB-	FW	B-ADVP	O
i.e.	i.e.	FW	I-ADVP	O
by	by	IN	B-PP	O
time	time	NN	B-NP	B-protein
pt	pt	NN	I-NP	I-protein
reached	reach	VBD	B-VP	I-protein
floor	floor	NN	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Additinally	Additinally	RB	B-ADVP	O
,	,	,	O	O
pt	pt	JJ	B-NP	O
HTN	HTN	NN	I-NP	O
to	to	TO	B-VP	O
sbp	sbp	VB	I-VP	O
170	170	CD	B-NP	O
and	and	CC	O	O
tachy	tachy	JJ	B-NP	O
100-110s	100-110	NNS	I-NP	O
:	:	:	O	O
given	give	VBN	B-NP	O
lopressor	lopressor	NN	I-NP	O
5mg	5mg	NN	I-NP	O
IV	IV	CD	I-NP	O
x2	x2	NN	I-NP	O
and	and	CC	I-NP	O
25mg	25mg	NN	I-NP	O
PO	PO	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
ASA	ASA	NN	B-NP	O
and	and	CC	I-NP	O
5000U	5000U	NN	I-NP	O
heparin	heparin	NN	I-NP	O
dose	dose	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
1000U/hr	1000U/hr	NN	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
repeatedly	repeatedly	RB	B-ADJP	O
hypoglhcemic	hypoglhcemic	JJ	I-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
once	once	RB	I-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
30s	30	NNS	I-NP	O
.	.	.	O	O

ROS	ROS	NNS	B-NP	O
:	:	:	O	O
endorses	endors	NNS	B-NP	O
chills	chill	NNS	I-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
occ	occ	NN	B-NP	O
non	non	JJ	I-NP	O
prod	prod	NN	I-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
tightness	tightness	NN	I-NP	O
,	,	,	O	O
subjective	subjective	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
fatigue	fatigue	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
recent	recent	JJ	B-NP	O
sickness	sickness	NN	I-NP	O
,	,	,	O	O
dysuria/vomit/diarrhea	dysuria/vomit/diarrhea	NN	B-NP	O
;	;	:	O	O
chronic	chronic	JJ	B-NP	O
2	2	CD	I-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
and	and	CC	I-NP	O
c/p	c/p	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
;	;	:	O	O
RUE	RUE	NN	B-NP	O
tremor	tremor	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
intermitttently	intermitttently	RB	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
stents	stent	NNS	I-NP	I-protein
x	x	SYM	O	I-protein
4	4	CD	B-NP	I-protein
,	,	,	O	O
LVEF	LVEF	NN	B-NP	O
35-40	35-40	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
AICD	AICD	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
inducible	inducible	JJ	I-NP	O
vt	vt	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
fem-tib	fem-tib	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hyperlipid	hyperlipid	NN	B-NP	O
,	,	,	O	O
glaucoma	glaucoma	NN	B-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
ECASA	ECASA	NN	I-NP	I-protein
325	325	CD	B-NP	I-protein
,	,	,	O	O
Terazosin	Terazosin	NN	B-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
25U	25U	NN	I-NP	O
qAM	qAM	NN	I-NP	O
5U	5U	NN	I-NP	O
qPM	qPM	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
20tid	20tid	CD	I-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
20	20	CD	I-NP	O
PO	PO	NN	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
30	30	CD	I-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	O
50	50	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
nephroaps	nephroap	NNS	B-NP	O
,	,	,	O	O
pepcid	pepcid	VBD	B-VP	O
SHx	SHx	NNP	B-NP	O
:	:	:	O	O
lives	life	NNS	B-NP	O
with	with	IN	B-PP	O
daughter	daughter	NN	B-NP	O
,	,	,	O	O
estranged	estrange	VBN	B-VP	O
from	from	IN	B-PP	O
husband	husband	NN	B-NP	O
,	,	,	O	O
evasive	evasive	JJ	B-ADJP	O
about	about	IN	B-PP	O
home	home	NN	B-NP	O
situation	situation	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
tob/etoh/illicit	tob/etoh/illicit	NN	I-NP	O
drugs	drug	NNS	I-NP	O
FHx	FHx	NN	I-NP	O
:	:	:	O	O
replete	replete	JJ	B-ADJP	O
with	with	IN	B-PP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HD	HD	NNP	B-NP	O
Admit	Admit	NNP	I-NP	O
exam	exam	VBP	B-VP	O
96.3	96.3	CD	B-NP	O
148/80	148/80	CD	I-NP	O
@	@	CD	I-NP	O
64	64	CD	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
NAD	NAD	NN	I-NP	O
R	R	NN	I-NP	O
ptosis	ptosis	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
cataract	cataract	NN	I-NP	O
,	,	,	O	O
R	R	NN	B-NP	B-protein
dilated	dilate	VBD	B-VP	O
opacified	opacifie	VBN	I-VP	O
cornea	cornea	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
reaction	reaction	NN	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
;	;	:	O	O
tongue	tongue	NN	B-NP	O
hematoma	hematoma	NN	I-NP	O
no	no	DT	B-NP	O
JVD	JVD	NN	I-NP	B-protein
RRR	RRR	NN	I-NP	I-protein
LLSB	LLSB	NN	I-NP	I-protein
systolic	systolic	JJ	I-NP	I-protein
murmur	murmur	NN	I-NP	I-protein
2/6	2/6	CD	I-NP	I-protein
CTAB	CTAB	NN	I-NP	I-protein
with	with	IN	B-PP	O
coarse	coarse	NN	B-NP	B-protein
BS	BS	NN	I-NP	I-protein
at	at	IN	B-PP	O
bases	base	NNS	B-NP	B-protein
Benign	Benign	JJ	B-NP	I-protein
abd	abd	NN	I-NP	I-protein
dp2	dp2	NN	I-NP	I-protein
+	+	SYM	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
cce	cce	NN	I-NP	O
,	,	,	O	O
wwp	wwp	NN	B-NP	O
CN	CN	NN	I-NP	O
III-XII	III-XII	CD	I-NP	O
intact	intact	JJ	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
+	+	SYM	I-NP	O
strength	strength	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
reflexes	reflex	NNS	I-NP	O
,	,	,	O	O
LABS	LABS	NNP	B-NP	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
2.2	2.2	CD	I-NP	O
LFT/pancrease	LFT/pancrease	NN	I-NP	O
wnl	wnl	NN	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
415	415	CD	I-NP	I-protein
MB	MB	NN	I-NP	I-protein
10.9	10.9	CD	B-NP	I-protein
TnI	TnI	NN	I-NP	I-protein
LTA	LTA	NN	I-NP	I-protein
;	;	:	O	O
UA	UA	NN	B-NP	O
slightly	slightly	RB	B-ADJP	O
dirty	dirty	JJ	I-ADJP	O
,	,	,	O	O
CXR	CXR	NN	B-NP	B-protein
clear	clear	JJ	I-NP	O
aside	aside	NN	I-NP	O
from	from	IN	B-PP	O
cardiomegaly	cardiomegaly	NN	B-NP	O
,	,	,	O	O
EKG	EKG	NNP	B-NP	O
--	--	:	O	O
LVH	LVH	NN	B-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
ST	ST	NN	B-NP	O
depressions	depression	NNS	I-NP	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
with	with	IN	B-PP	O
normoglycemia/anti-anginals	normoglycemia/anti-anginal	NNS	B-NP	O
Impression	Impression	NN	I-NP	O
:	:	:	O	O
demand	demand	NN	B-NP	O
related	related	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
2/2	2/2	CD	I-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
once	once	IN	B-SBAR	O
she	she	PRP	B-NP	O
arrived	arrive	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
for	for	IN	B-PP	O
that	that	DT	B-NP	O
matter	matter	NN	I-NP	O
,	,	,	O	O
SOB/N/V	SOB/N/V	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
initally	initally	RB	B-ADVP	O
had	have	VBD	B-VP	O
difficulty	difficulty	NN	B-NP	O
maintaining	maintain	VBG	B-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
another	another	DT	B-NP	O
amp	amp	NN	I-NP	O
of	of	IN	B-PP	O
d50	d50	NN	B-NP	B-protein
and	and	CC	I-NP	O
orange	orange	NN	I-NP	O
juice	juice	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
consistently	consistently	RB	B-ADVP	O
over	over	IN	B-PP	O
120	120	CD	B-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
enzyme	enzyme	NN	I-ADJP	O
posive	posive	JJ	I-ADJP	O
for	for	IN	B-PP	O
NSTEMI	NSTEMI	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
MB	MB	NN	I-NP	O
31.2	31.2	CD	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
32.4	32.4	CD	O	O
--	--	SYM	O	O
>	>	SYM	O	O
15.4	15.4	CD	B-NP	O
today	today	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
recur	recur	VB	I-VP	O
.	.	.	O	O

IN	IN	IN	B-PP	O
fact	fact	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
normal	normal	JJ	B-ADJP	O
since	since	IN	B-PP	O
arriving	arrive	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
demand	demand	NN	B-NP	O
related	related	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
.	.	.	O	O

Causes	Cause	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
included	include	VBD	B-VP	O
hypoth	hypoth	NN	B-NP	O
yroidism	yroidism	NN	I-NP	O
,	,	,	O	O
adrenal	adrenal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
iatrogenesis	iatrogenesis	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
finite	finite	JJ	I-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
possibility	possibility	NN	I-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
most	most	RBS	B-NP	O
likely	likely	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TSH	TSH	NN	I-NP	O
,	,	,	O	O
AM	AM	VBP	B-VP	O
cortisol	cortisol	NN	B-NP	O
wnl	wnl	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
peaked	peak	VBN	I-VP	O
-LRB-	-LRB-	NN	B-NP	O
MB	MB	NN	I-NP	O
:	:	:	O	O
31.2	31.2	CD	B-NP	O
--	--	:	O	O
>	>	SYM	O	O
31.4	31.4	CD	O	O
--	--	SYM	O	O
>	>	SYM	O	O
15.4	15.4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
situation	situation	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
previouisly	previouisly	RB	I-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
suboptimal	suboptimal	JJ	B-ADJP	O
--	--	:	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
son	son	NN	I-NP	O
who	who	WP	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
dealing	deal	VBG	I-VP	O
drugs	drug	NNS	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
2	2	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
over	over	IN	B-PP	O
potential	potential	JJ	B-NP	O
tension	tension	NN	I-NP	O
betwee	betwee	IN	B-PP	O
her	her	PRP	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
estranged	estranged	JJ	I-NP	O
husband	husband	NN	I-NP	O
or	or	CC	I-NP	O
medication	medication	NN	I-NP	O
errors	error	NNS	I-NP	O
.	.	.	O	O

Social	Social	JJ	B-NP	O
work	work	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
and	and	CC	O	O
spoke	speak	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
appropriately	appropriately	RB	I-VP	O
concerned	concern	VBN	I-VP	O
about	about	IN	B-PP	O
her	her	PRP$	B-NP	O
mother	mother	NN	I-NP	O
's	's	POS	B-NP	O
health	health	NN	I-NP	O
and	and	CC	O	O
open	open	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
idea	idea	NN	I-NP	O
of	of	IN	B-PP	O
placement	placement	NN	B-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
assisted	assist	VBN	I-NP	O
living	live	VBG	I-NP	O
facility	facility	NN	I-NP	O
at	at	IN	B-PP	O
some	some	DT	B-NP	O
later	later	JJ	I-NP	O
date	date	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
an	an	DT	B-NP	O
elaborate	elaborate	JJ	I-NP	O
and	and	CC	I-NP	O
effective	effective	JJ	I-NP	O
system	system	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
worked	work	VBN	I-VP	O
out	out	RP	B-PRT	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
and	and	CC	I-VP	O
treat	treat	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patients	patient	NNS	I-NP	O
visiting	visit	VBG	B-VP	O
nurse	nurse	NN	B-NP	O
service	service	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Lan	Lan	NNP	I-NP	O
Xiemore	Xiemore	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
was	be	VBD	B-VP	O
contacted	contact	VBN	I-VP	O
to	to	TO	I-VP	O
reemphasize	reemphasize	VB	I-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
evaluating	evaluate	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
nurse	nurse	NN	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
care	care	NN	I-NP	O
also	also	RB	B-ADVP	O
will	will	MD	B-VP	O
initiate	initiate	VB	I-VP	O
a	a	DT	B-NP	O
request	request	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
health	health	NN	I-NP	O
aide	aide	NN	I-NP	O
to	to	TO	B-VP	O
visit	visit	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
more	more	RBR	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
.	.	.	O	O

Elder	Elder	NN	B-NP	O
services	service	NNS	I-NP	O
was	be	VBD	B-VP	O
informed	inform	VBN	I-VP	O
to	to	TO	I-VP	O
initiate	initiate	VB	I-VP	O
a	a	DT	B-NP	O
consult	consult	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
social	social	JJ	I-NP	O
worker	worker	NN	I-NP	O
at	at	IN	B-PP	O
Centter	Centter	NNP	B-NP	O
Ing	Ing	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
informed	inform	VBN	I-VP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
situation	situation	NN	I-NP	O
is	be	VBZ	B-VP	O
deemed	deem	VBN	I-VP	O
safe	safe	JJ	B-ADJP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Fowlie	Fowlie	NNP	I-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
VNA	VNA	NNP	I-NP	O
will	will	MD	B-VP	O
visit	visit	VB	I-VP	O
her	her	PRP$	B-NP	O
tommorrow	tommorrow	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
dropped	drop	VBD	B-VP	O
slightly	slightly	RB	B-ADVP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
dischar	dischar	NN	B-NP	O
ge	ge	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Parenthetically	Parenthetically	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
dirty	dirty	JJ	I-NP	O
UA	UA	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
but	but	CC	I-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Your	Your	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
dosage	dosage	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
decreased	decrease	VBN	I-VP	O
because	because	IN	B-SBAR	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
was	be	VBD	B-VP	O
too	too	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
visiting	visit	VBG	I-NP	O
nurse	nurse	NN	I-NP	O
should	should	MD	B-VP	O
check	check	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
physician	physician	NN	I-NP	O
if	if	IN	B-SBAR	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
consistently	consistently	RB	B-ADVP	O
above	above	IN	B-PP	O
150	150	CD	B-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
lipitor	lipitor	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
increased	increase	VBN	I-VP	O
because	because	IN	B-SBAR	O
your	your	PRP$	B-NP	O
LDL	LDL	NN	I-NP	B-protein
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
92	92	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
LEVARIO	LEVARIO	NNP	B-NP	O
,	,	,	O	O
STEPHEN	STEPHEN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MG74	MG74	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/18/04	10/18/04	CD	I-NP	O
@	@	SYM	B-NP	O
04	04	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

